PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes

Cell Death and Differentiation
L LarribereC Bertolotto

Abstract

Melanocytes are cells of the epidermis that synthesize melanin, which is responsible for skin pigmentation. Transformation of melanocytes leads to melanoma, a highly aggressive neoplasm, which displays resistance to apoptosis. In this report, we demonstrate that TNF-related apoptosis-inducing ligand (TRAIL), which was thought to kill only transformed cells, promotes very efficiently apoptosis of primary human melanocytes, leading to activation of caspases 8, 9 and 3, and the cleavage of vital proteins. Further, we show that stem cell factor (SCF), a physiologic melanocyte growth factor that activates both the phosphatidyl-inositol-3 kinase (PI3K) and the extracellular regulated kinase (ERK) pathways, strongly protects melanocytes from TRAIL and staurosporine killing. Interestingly, inhibition of PI3K or its downstream target AKT completely blocks the antiapoptotic effect of SCF, while inhibition of ERK has only a moderate effect. Our data indicate that protection evoked by SCF/PI3K/AKT cascade is not mediated by an increase in the intracellular level of FLIP. Further, only a sustained PI3K activity can protect melanocytes from apoptosis, thereby indicating that the PI3K/AKT pathway plays a pivotal role in melanocyte survival. T...Continue Reading

References

Jan 1, 1997·Immunology Today·G KroemerS A Susin
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Oct 31, 1998·Current Opinion in Immunology·M E Peter, P H Krammer
Nov 11, 1998·General Pharmacology·A Gescher
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Oct 6, 2000·The American Journal of Pathology·X P ZhouC Eng
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·W D ThomasP Hersey
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer·H HelmbachD Schadendorf
Sep 21, 2001·Nature·F P NoonanG Merlino
Jan 5, 2002·Neoplasia : an International Journal for Oncology Research·R K Srivastava
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jun 19, 2002·American Journal of Clinical Dermatology·Carol L HuangRaymond Boissy
Oct 19, 2002·Biochimica Et Biophysica Acta·Luca M NeriAlberto M Martelli
Nov 26, 2002·Nature Genetics·Pamela M PollockPaul S Meltzer
Feb 13, 2003·The Journal of Pathology·Mahmoud R HusseinGary S Wood
Mar 26, 2003·Cell Death and Differentiation·H N LeBlanc, A Ashkenazi
Jul 30, 2003·Cancer Metastasis Reviews·Kaladhar B ReddyNatasha Atanaskova
Aug 15, 2003·The Journal of Biological Chemistry·Armelle CalipelFrédéric Mascarelli
Aug 30, 2003·Cancer Causes & Control : CCC·Philippe AutierUNKNOWN European Organisation for Research and Treatment of Cancer Melanoma Group
Sep 23, 2003·The American Journal of Dermatopathology·Pablo UribeSergio González
Oct 29, 2003·The Journal of Experimental Medicine·Takashi MurakamiSam T Hwang
Nov 26, 2003·Biochemical and Biophysical Research Communications·Taiichiro MiyashitaKatsumi Eguchi
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Henning Schulze-BergkamenPeter H Krammer

❮ Previous
Next ❯

Citations

Aug 24, 2006·Apoptosis : an International Journal on Programmed Cell Death·D Y LegerJ L Beneytout
Feb 18, 2009·Apoptosis : an International Journal on Programmed Cell Death·Saskia LippensWim Declercq
Jun 30, 2005·Cancer Metastasis Reviews·Gavin P Robertson
Aug 6, 2013·American Journal of Clinical Dermatology·Carlos R Camara-Lemarroy, Julio C Salas-Alanis
Jul 3, 2010·Cell Death and Differentiation·T BottonS Rocchi
Sep 18, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D LaneA Piché
Apr 23, 2008·Pigment Cell & Melanoma Research·C HilmiC Bertolotto
Jun 6, 2009·Pigment Cell & Melanoma Research·Subbarao V Madhunapantula, Gavin P Robertson
Dec 3, 2013·Journal of Dermatological Science·Anne PierronThierry Passeron
May 1, 2007·Expert Opinion on Therapeutic Targets·Konstantinos Drosopoulos, Alexander Pintzas
Dec 15, 2007·The Journal of Investigative Dermatology·Caroline HilmiCorine Bertolotto
Dec 10, 2009·Molecular Aspects of Medicine·Gregory MellierShazib Pervaiz
Dec 23, 2011·The Journal of Investigative Dermatology·Joanne SoongGlynis A Scott
Jan 30, 2009·The Journal of Investigative Dermatology·Thomas BottonStephane Rocchi
Sep 9, 2006·The Journal of Investigative Dermatology·Cédric GaggioliSophie Tartare-Deckert
Sep 16, 2006·Immunological Reviews·Thomas F GajewskiHelena Harlin
Nov 22, 2005·Journal of Autoimmunity·Thierry Passeron, Jean-Paul Ortonne
Sep 28, 2013·Journal of Receptor and Signal Transduction Research·Lior DrukkerHannah Ben Bassat
Dec 4, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Young Je AhnJong Hoon Ryu
Feb 18, 2004·Oncogene·Tilman BrummerMichael Reth
Apr 28, 2005·Oncogene·Aurélien G DupuyJean de Gunzburg

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis